News

Episode 6: – Dr. Veronica Dell’Acqua and Prof. Cihan Gani – Hypothesis Testing Program and MR-Adaptive Dose Escalated Radiotherapy in Rectal Cancer (MARS Trial)

Grab your headphones and tune into RadChat‘s latest pod. This is the 6th episode in our MR Linac series with Dr. Veronica Dell’Acqua and Prof. Cihan Gani discussing the Hypothesis Testing Program and MR-Adaptive Dose Escalated Radiotherapy in Rectal Cancer (MARS Trial) LISTEN HERE and on all podcast libraries such as Spotify, Apple podcasts, Audible and …

Read More… from Episode 6: – Dr. Veronica Dell’Acqua and Prof. Cihan Gani – Hypothesis Testing Program and MR-Adaptive Dose Escalated Radiotherapy in Rectal Cancer (MARS Trial)

Destination 1 – A study of dose de-escalation in prostate radiotherapy 

DESTINATION is a novel and exciting feasibility study of dose de-escalation in prostate radiotherapy. It is now open to recruitment with patients having been treated at all three participating centres: Royal Marsden Hospital (RMH), Sunnybrook Health Sciences Centre and Netherlands Cancer Institute (NKI). In DESTINATION men with intermediate-risk prostate cancer will receive 30 Gy in …

Read More… from Destination 1 – A study of dose de-escalation in prostate radiotherapy